Bandhan Bank shares jumped more than 7% in morning trade after receiving positive reviews from various brokerage firms.
Here’s what major brokerages said:
| Brokerage Firm | Rating | Target Price (₹) | Upside/Downside % | Key Insights |
|---|---|---|---|---|
| Jefferies | Buy | 240 | +27.7% | New MD & CEO appointment seen as a positive, with past stress clearing up. Bandhan is expected to benefit from CGFMU claim and recoveries that add to its profit pool. |
| Goldman Sachs | Positive | N/A | N/A | MD & CEO appointment and CGFMU claim resolution remove near-term overhang, with the focus now shifting to the bank’s fundamentals and reducing investor uncertainty. |
| CLSA | Positive | N/A | N/A | Key overhangs have cleared, and the focus is back on fundamentals. Benign near-term delinquency outlook for MFI segment; expect a rerating of the stock. |
As of 9:16 am, Bandhan Bank shares were trading 7.91% higher at Rs 201.53 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
TOPICS:
Bandhan Bank